Theorem Clinical Research

R&D Trends

With NIH Grant, Cedars-Sinai brings big data to neuro disease research

Thursday, October 2, 2014 02:23 PM

Investigators at the Los Angeles Cedars-Sinai Regenerative Medicine Institute have received a grant from the NIH to participate in a consortium taking the study of motor neuron disorders—such as Lou Gehrig's disease and spinal muscular atrophy—to a new, comprehensive perspective.

More... »


CORD:USE, Tianhe Stem Cell Biotechnologies partner

Thursday, October 2, 2014 02:20 PM

CORD:USE Cord Blood Bank, headquartered in Orlando, Fla., an operator of both public and family cord blood banks, has entered into an agreement with Illinois–based Tianhe Stem Cell Biotechnologies, which has licensed a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications.

More... »


National MS Society invests nearly $19 million in MS research

Thursday, October 2, 2014 02:16 PM

The National Multiple Sclerosis (MS) Society has committed nearly $19 million to support an expected 54 new MS research projects. These are part of a comprehensive research strategy aimed at stopping MS, restoring function that has been lost and ending the disease forever.

More... »

BioNTech, Ganymed Pharmaceuticals open research headquarters in Germany

Thursday, October 2, 2014 02:14 PM

BioNTech and Ganymed Pharmaceuticals, two German biotechology companies, have opened a 108,000-square-foot headquarters and research facility. The new facility brings together 300 employees and is located near academic institutions, hospitals and cancer research institutions.

More... »

NHS chief Simon Stevens launches $1M prize fund for innovation

Thursday, October 2, 2014 02:11 PM

Simon Stevens, NHS chief executive, has launched a $1 million prize pot to reward innovation in the NHS. The NHS Innovation Challenge Prize encourages, celebrates and rewards innovation driven by the frontline doctors, nurses and NHS staff who deliver care every day. 

More... »

NIBSC signs agreement with UCL

Thursday, October 2, 2014 02:09 PM

A memorandum of understanding has been signed between the National Institute for Biological Standards and Control and University College London (UCL). The memorandum states that both parties should share common goals to help safeguard and enhance public health in the U.K. and elsewhere. Best available science should be applied to the international harmonization of standards for characterization, production and distribution, and the availability of cell lines and other key materials of appropriate quality for research and clinical use should be facilitated.

More... »

Glialogix, National Multiple Sclerosis Society collaborate

Thursday, October 2, 2014 02:08 PM

Glialogix, a San Francisco Bay Area-based emerging biopharma company, has entered into a sponsored research agreement with Fast Forward, a nonprofit organization established by the New York-based National Multiple Sclerosis (MS) Society to accelerate the development of treatments for MS. Fast Forward will provide funding for preclinical studies of GLX1112, a first-in-class neuroprotective therapy designed to slow the accumulation of disability in progressive MS.

More... »

Baxter to form new innovation and R&D center for biopharmaceuticals

Wednesday, October 1, 2014 01:26 PM

Baxter International plans to form a new global innovation and R&D center in Cambridge, Mass., for Baxter's biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta in mid-2015.

More... »

PCORI approves $102M in support of 46 new research projects

Wednesday, October 1, 2014 01:23 PM

The Patient-Centered Outcomes Research Institute (PCORI), a Wash. D.C.-based independent nonprofit organization, has approved 46 new proposals, totaling nearly $102 million in support, to fund a wide range of patient-centered clinical comparative effectiveness research (CER) projects.

More... »

NIH awards initial $46 million for BRAIN Initiative research

Wednesday, October 1, 2014 01:21 PM

The NIH has announced its first wave of investments totaling $46 million in fiscal year 2014 to support the goals of the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative. More than 100 investigators in 15 states and several countries will work to develop new tools and technologies to understand neural circuit function and capture a dynamic view of the brain in action.

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs